Business & Finance
Adolor discontinues sales force and reports other selected work force reductions
Published in Medical Letter on the CDC and FDA, January 14th, 2007
The company established its sales force in early 2005 in anticipation of a product launch for Entereg (alvimopan) for the management of postoperative ileus later that year. The recent Food and Drug Administration (FDA) approvable letter and subsequent delay to possible market entry for the company's lead product Entereg was the impetus for the decision. The sales force has been detailing GlaxoSmithKline's (GSK) anti-thrombotic agent Arixtra under its co-promotion agreement with GSK, which expired on December 31,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer Vaccines
Data from University of Pittsburgh, Pittsburgh Cancer Institute advance knowledge in cancer vaccines - Alzheimer Disease
Memory Pharmaceuticals reports U.S. FDA release of clinical hold on Alzheimer drug MEM 3454 - Anemia
Data show efficacy of extended dosing of Aranesp in treatment of chemotherapy-induced anemia - Anemia
Phase II data show promise of Aranesp treatment for anemia of cancer - Business & Finance
Migenix updates celgosivir hepatitis C study data, reports Q2 2007 $3.7 million loss - Business Update
Barr confirms generic Thalomid capsule application - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
